3Gravitt PE, Paul P, Katki HA, et al. Effectiveness of VIA,Pap, and HPV DNA testing in a cervical cancer screening program in a periurban community in Andhra Pradesh, India[ J] . PLoS One, 2010,5 ( 10 ) : 13711.
4Cusehieri KS, Cubie HA, Whitley MW, et al. Multiple high risk HPV infection are common in cervical ncoplasia and young women in a cervical screening populationl[J]. J Clin Pathol,2004,57 ( 1 ) :68 - 72.
5Kim CJ, Jeong JK, Par k M, et al. HPV oligonucleotide microarray - based detection of HPV genotypes in cervical neoplastic lesions [ J] . Gynecol On col, 2003,89(2) :210 -217.
6Harper DM , Franco EL, Wheeler C, et al. Efficacy of a bivalent L1 virus like particle vaccine in prevention of infection with human papil- lomavirus types 16 and 18 in young women: a randomised controlled trial [J]. Lancet,2004,364(9447) :1757 - 1765.
7Brandsma JL, Shlyankevich M, Zelterman D, et al. Therapeutic vac- cination of rabbits with a ubiquitin - fused papillomavirus El, E2, E6 and E7 DNA vaccine[ J]. Vaccine,2007,25 (33) :6158 - 6163.
